Nvigen
Company

Last deal

$1.1M

Amount

Series B

Stage

18.03.2014

Date

3

all rounds

$1.1M

Total amount

General

About Company
NVIGEN is a nanobiotechnology company that revolutionizes multifunctional nanoparticles for biomedical applications.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

The company was founded in Silicon Valley and develops nanoparticle research reagents and devices for biomedical research applications. Their proprietary nanochemistry technology enables the engineering of nanoparticles with optimal size, shape, surface, magnetic and optical properties, which can be used in sequencing, biopsy, genomics, diagnostics, gene/cell therapy, and drug delivery. The company's nanoparticle-imaging-delivery (NID) platform integrates the versatility of nanoscience and innovation to empower biomedical research by efficiently capturing and identifying molecular information from proteins, cells, and nucleic acids.
Contacts

Social url